Financials: Immunodiagnostic Systems Hldgs PLC (IDH.L)
IDH.L on London Stock Exchange
685.00GBp
3:51am EST
685.00GBp
3:51am EST
Price Change (% chg)
12.50p (+1.86%)
12.50p (+1.86%)
Prev Close
672.50p
672.50p
Open
670.00p
670.00p
Day's High
685.00p
685.00p
Day's Low
670.00p
670.00p
Volume
6,000
6,000
Avg. Vol
40,029
40,029
52-wk High
780.00p
780.00p
52-wk Low
130.50p
130.50p
Revenue
Earnings Per Share
Consensus Estimates Analysis
No consensus analysis data available.
Sales and Earnings Figures in U.S. Dollars (USD)
Valuation Ratios
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| P/E Ratio (TTM) | 28.11 | 4.05 | 3.76 | 14.59 |
| P/E High - Last 5 Yrs. | -- | 3.64 | 1.59 | 16.18 |
| P/E Low - Last 5 Yrs. | -- | 1.04 | 0.55 | 4.36 |
| Beta | 0.93 | 0.61 | 0.65 | 1.33 |
| Price to Sales (TTM) | 6.03 | 0.56 | 1.22 | 2.01 |
| Price to Book (MRQ) | 3.19 | 2.84 | 1.99 | 2.58 |
| Price to Tangible Book (MRQ) | -- | 3.88 | 3.19 | 5.66 |
| Price to Cash Flow (TTM) | 20.93 | 2.51 | 2.07 | 7.12 |
| Price to Free Cash Flow (TTM) | -- | 21.54 | 24.92 | 12.79 |
| % Owned Institutions | -- | -- | -- | -- |
Dividends
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Dividend Yield | -- | 0.12 | 0.29 | 1.71 |
| Dividend Yield - 5 Year Avg. | 0.66 | 0.89 | 1.60 | 2.35 |
| Dividend 5 Year Growth Rate | -- | 13.13 | 15.63 | -5.31 |
| Payout Ratio(TTM) | 6.66 | 2.46 | 4.46 | 24.71 |
Growth Rates
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 56.00 | 7.82 | 6.84 | 10.73 |
| Sales (TTM) vs TTM 1 Yr. Ago | 36.43 | 0.36 | 1.90 | -4.74 |
| Sales - 5 Yr. Growth Rate | 41.14 | 7.38 | 8.05 | 7.42 |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 189.68 | 94.86 | 142.38 | 98.28 |
| EPS (TTM) vs TTM 1 Yr. Ago | 104.48 | -- | -- | -- |
| EPS - 5 Yr. Growth Rate | -- | 12.77 | 5.61 | 8.85 |
| Capital Spending - 5 Yr. Growth Rate | 56.67 | 11.47 | 6.95 | 5.91 |
Financial Strength
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Quick Ratio (MRQ) | 1.28 | 1.94 | 2.57 | 0.81 |
| Current Ratio (MRQ) | 1.85 | 2.53 | 3.05 | 0.95 |
| LT Debt to Equity (MRQ) | 16.95 | 16.53 | 25.13 | 127.01 |
| Total Debt to Equity (MRQ) | 23.68 | 29.33 | 32.96 | 179.52 |
| Interest Coverage (TTM) | -- | 4.54 | 3.69 | 11.83 |
Profitability Ratios
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Gross Margin (TTM) | 72.12 | 10.96 | 12.78 | 31.64 |
| Gross Margin - 5 Yr. Avg. | 64.28 | 47.78 | 56.69 | 29.11 |
| EBITD Margin (TTM) | 34.89 | -- | -- | -- |
| EBITD - 5 Yr. Avg | 25.19 | 20.20 | 16.23 | 15.13 |
| Operating Margin (TTM) | 27.20 | 3.40 | -4.90 | -- |
| Operating Margin - 5 Yr. Avg. | 20.32 | 14.98 | 12.24 | 17.30 |
| Pre-Tax Margin (TTM) | 25.06 | 3.05 | -4.88 | 12.47 |
| Pre-Tax Margin - 5 Yr. Avg. | 18.57 | 14.64 | 14.23 | 16.97 |
| Net Profit Margin (TTM) | 21.11 | 2.34 | -5.71 | 9.80 |
| Net Profit Margin - 5 Yr. Avg. | 14.85 | 9.68 | 7.73 | 12.33 |
| Effective Tax Rate (TTM) | 15.73 | 4.20 | 3.58 | 14.83 |
| Effecitve Tax Rate - 5 Yr. Avg. | 20.02 | 28.78 | 34.40 | 26.46 |
Efficiency
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 991,736 | 1,282,917 | 299,091 |
| Net Income/Employee (TTM) | -- | 70,367 | 213,959 | 26,863 |
| Receivable Turnover (TTM) | 4.11 | 0.87 | 0.89 | 8.07 |
| Inventory Turnover (TTM) | 1.55 | 0.45 | 0.64 | 5.03 |
| Asset Turnover (TTM) | 0.42 | 0.13 | 0.12 | 0.44 |
Management Effectiveness
| Company | Industry | Sector | S&P 500 | |
|---|---|---|---|---|
| Return on Assets (TTM) | 8.86 | 1.60 | 1.78 | 4.25 |
| Return on Assets - 5 Yr. Avg. | 7.93 | 7.52 | 6.74 | 4.83 |
| Return on Investment (TTM) | 10.29 | 2.37 | 2.30 | 5.67 |
| Return on Investment - 5 Yr. Avg. | 9.45 | 10.24 | 8.69 | 6.33 |
| Return on Equity (TTM) | 14.03 | 3.77 | 2.82 | 12.56 |
| Return on Equity - 5 Yr. Avg. | 13.45 | 12.40 | 10.04 | 12.84 |
| 1 Year | 3 Years | 5 Years | |
|---|---|---|---|
| Sales % | 51.40 | 45.28 | 41.14 |
| EPS % | 21.29 | 39.38 | -- |
| Dividend % | 10.00 | 18.17 | -- |
Note: Units in Millions of US Dollars
Performance for Immunodiagnostic Systems Hldgs PLC
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -2.17 | 6.20 | 53 | 82 |
| 13 Week | 31.71 | 35.24 | 97 | 58 |
| 26 Week | 106.11 | 91.25 | 99 | 87 |
| 52 Week | 386.49 | 301.36 | 99 | 85 |
| YTD | -7.22 | -1.83 | 24 | 42 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 29.02% |
| # of Holders: | 28 |
| Total Shares Held: | 8,044,395 |
| 3 Mo. Net Change: | 33,891 |
| # New Positions: | 3 |
| # Closed Positions: | 3 |
| # Increased Positions: | 7 |
| # Reduced Positions: | 11 |
| # Net Buyers: | -4 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.





